Concepedia

Sarah J. Firdaus

SJ

Statistics

Publications

6

Citations

2K

H-Index

6

Active since

2012

Affiliations

Wellspring Biosciences (United States)(Current)

Oklahoma State University

Kura Oncology (United States)

Sarah J. Firdaus is an author at Wellspring Biosciences (United States) specializing in lipid metabolism, kras-targeted therapy, and oncology.

ORCID

Publications per year

2012–2022

6

Publications

6

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.2K citations · Full text

, , +12

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li et al. · Cancer Discovery · 2016 · 754 citations · Full text

, , +17

Developmental changes in the protein composition of Manduca sexta lipid droplets

José L. Soulages, Sarah J. Firdaus, Steve Hartson et al. · Insect Biochemistry and Molecular Biology · 2012 · 28 citations · Full text

, , +15

Monoacylglycerol and diacylglycerol acyltransferases and the synthesis of neutral glycerides in Manduca sexta

José L. Soulages, Zengying Wu, Sarah J. Firdaus et al. · Insect Biochemistry and Molecular Biology · 2014 · 19 citations

, , +16

PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib

Xia Ding, Zhou Zhu, John D. Lapek et al. · Scientific Reports · 2022 · 14 citations · Full text

, , +17

1–5 of 6